Buy Havells India, CESC: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "The idea is to go long. There are two buying opportunities in midcaps, the first is in Havells India. The stock is making lifetime new highs and that is good enough. The second is in CESC. It is a speculative momentum driven stock. The momentum fortunately for buyers is on the upside. So, buying this stock at current levels probably should give gains in the next couple of days."

"Dr Reddys Laboratories is a heavyweight Nifty stock. The stock went through a correction and is now rallying. It is a little out of favour because it is not that risk on stock but risk on has its own advantages and buying a laid back stock like Dr Reddy's has its own plus points. We are already buying the Nifty and Bank Nifty for risk on," he said.